ClinicalTrials.gg
Active, not recruitingNCT07912489OD CW CCW PSUpdated Nov 3, 2026

Effectiveness of Clockwise vs. Counter-Clockwise Osseodensification for Implant Site Preparation

An interventional study of Clockwise Cutting with Densah Burs and Counter-Clockwise Osseodensification with Densah Burs in Osseodensification Drilling Technique, sponsored by University of Science and Technology, Yemen. Active, not recruiting at 1 site in Yemen. Open to female participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by University of Science and Technology, Yemen · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Jan 2026, registered Sep 2026).
Updated Nov 3, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
Female
01

Study summary

This study aims to compare the primary stability of dental implants placed using two different rotational modes of the Densah burs (Clockwise Cutting vs. Counter-Clockwise Osseodensification) under a fully guided protocol. The primary outcomes are peak insertion torque and immediate implant stability quotient (ISQ).

Read the detailed description

Achieving adequate primary stability in low-density bone remains a clinical challenge. Osseodensification (OD) has been introduced to preserve and compact bone during implant site preparation. Densah burs are unique as they can be operated in two rotational directions: clockwise (CW) for cutting and counter-clockwise (CCW) for densification. However, no randomized human study has directly compared these two modes using the same burs under a fully guided protocol. This study is a prospective, randomized, double-blind, split-mouth controlled clinical trial. Each participant will receive two implants at clinically comparable sites in the same jaw. One site will be prepared using CW cutting mode, and the paired site will be prepared using CCW osseodensification mode. Both interventions will be performed using the same Universal Densah burs, the same fully guided R2GATE surgical guide, and identical implant dimensions to isolate the effect of rotational direction.

The primary outcome is peak insertion torque (IT). Secondary outcomes include immediate implant stability quotient (ISQ) and the correlation between IT and ISQ within each preparation mode. This study will provide the first direct clinical evidence to guide clinicians in selecting the optimal rotational mode for implant site preparation.

02

Conditions studied

  • Osseodensification Drilling Technique

Keywords

  • Osseodensification
  • Densah Burs
  • Primary Stability
  • ISQ
03

In context

Lead sponsor

University of Science and Technology, Yemen is the lead sponsor of 9 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult females aged 18 to 70 years.
  • Able to provide written .
  • Clinical indication for two endosseous dental implants at clinically comparable sites in the same participant.
  • Edentulous sites (healed or not fully healed) with sufficient bone volume. Minor bone augmentation is permitted only if identical at both paired sites.
  • Comparable paired sites regarding jaw, region, and planned implant diameter and length. The same implant dimensions must be used at both sites.
  • Bone density corresponding to D2 or D3 (350-1250 HU); dense D1 sites are excluded.
  • Good oral hygiene and periodontal stability.
  • Adequate inter-arch space and mouth opening for fully guided surgery.

Exclusion criteria

Exclusion Criteria:

  • Uncontrolled systemic disease.
  • Pregnancy or lactation.
  • Previous high-dose radiotherapy to the jaws or current chemotherapy.
  • Current intravenous antiresorptive therapy (e.g., bisphosphonates).
  • Heavy smoking (> 10 cigarettes/day) or substance abuse.
  • Severe parafunctional habits.
  • Active infection or untreated periodontitis at the planned sites.
  • Sites requiring different grafting procedures between the two sides.
  • D1 dense cortical bone or inability to perform the CCW protocol.
  • Inability to obtain two comparable eligible sites.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
10 participants (estimated)

Study arms

  • Active comparator
    Osseodensification technique CCW

    Procedure: Counter-Clockwise Osseodensification with Densah Burs

  • Experimental
    Osseodensification technique CW

    Implant site preparation performed using Densah burs in clockwise cutting direction under a fully guided protocol

    Procedure: Clockwise Cutting with Densah Burs

Interventions

  • ProcedureClockwise Cutting with Densah Burs

    Osteotomy site preparation performed in a clockwise cutting direction using Densah burs following a fully guided protocol

  • ProcedureCounter-Clockwise Osseodensification with Densah Burs

    Osteotomy site preparation performed in counter-clockwise direction using Densah burs following a fully guided protocol to achieve osseodensification

06

What researchers measure

Primary outcomes

  1. Peak Insertion Torque (IT)

    Peak torque required to seat the implant at the planned final position, measured in N/CM using a calibrated surgical motor or a calibrated torque device.

    Time frame: Immediately at implant placement (intraoperative).

Secondary outcomes

  1. Immediate Implant Stability Quotient (ISQ)

    Arithmetic mean of mesial, distal, buccal, and lingual resonance frequency reading measured using the Osstell device. ISQ ranges from 1 to 100, with higher values indicating greater stability.

    Time frame: Immediately after implant placement (intraoperative).

  2. Correlation between Insertion Torque and Immediate ISQ.

    Pearson or Spearman correlation coefficient between insertion torque (N/cm) and mean ISQ within each rotational mode.

    Time frame: Immediately after implant placement (intraoperative).

07

Study locations

1 site
  • UST
    Sanaa, Yemen
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared to protect patient confidentiality and privacy, as the dataset contains sensitive clinical information and specific implant coordinates.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2026 (actual). Primary completion is estimated for Oct 2026, 9 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 10, 2026
First posted
Nov 3, 2026
StartActual
Jan 5, 2026
Primary completionEst.
Oct 31, 2026
CompletionEst.
Nov 15, 2026
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07912489
Lead sponsor
University of Science and Technology, Yemen
Responsible party
Yahya Alwani (Principal Investigator, University of Science and Technology, Yemen) — Principal investigator
First posted
Nov 3, 2026
Start date
Jan 5, 2026
Primary completion
Oct 31, 2026 (estimated)
Completion
Nov 15, 2026 (estimated)
Last update
Nov 3, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion